A study was performed in Uruguay to estimate the prevalence of drug consumption during pregnancy. The study consisted of a survey and biological samples to validate the responses and investigate information concerning risks involved in drug consumption during pregnancy. The survey consisted of 900 face-to-face interviews performed within 48 hours after birth. Perinatal registries were taken from hospital archives. Nine hundred meconium samples were tested for alcohol, tobacco, illegal drugs, and tranquilizers. The results of the survey indicated consumption during pregnancy of the following: 41.3% tobacco, 36.8% alcohol, 16.3% tranquilizers, 68% caffeine (more than 400 mg/day), and 1.4% illegal drugs. In addition, 8.9% of the pregnancies were unplanned. Among the planned pregnancies, some physicians warned their patients about risks associated with tobacco (34%), alcohol (27%) and illegal drugs (7%). Meconium analysis revealed tobacco (cotinine), 51.8%; alcohol (fatty acid ethyl esters, or FAEES), 43.5%; and cocaine (base paste), 2.5%. Newborns whose mothers smoked tobacco presented statistically lower birth weights: 11% of all newborns at low birth weight, with health problems reported for 14.8%.
AbateP.ApearN. & MolinaJ. C. (2001). Alcohol Fetal and Infantile Alcohol mediated Associative learning in the rat. Alcoholism in Clinical Experimental Research, 25(7), 989–998.
2.
AlvearA. J.AndreaniS. & CortesM. F. (1988). Síndrome de alcoholismo fetal y efectos del alcohol sobre el feto: Importαncia del diagnostico precoz y del manejo nutricional (Fetal alcohol syndrome and effects of alcohol on the fetus: Importance of early diagnosis and nutritional management). Revista Médica de Chile, 126(4), 407–412.
3.
American Academy of Pediatrics Committee on Substance Abuse (1995). Drug-exposed infants. Pediatrics, 96(2), part 1, 364–367.
4.
American Academy of Pediatrics Committee on Substance Abuse & Committee on Children with Disabilities (2000). Fetal alcohol syndrome and alcohol-related neurodevelopment disorders. Pediatrics, 106(2), 358–361.
5.
BaranowskiJ.PochopienG. & BaranowskaI. (1998). Determination of nicotine, cotinine and caffeine in meconium using high-performance liquid chromatography. Journal of Chromatography B: Biomedical Science Applications, 707(1–2), 317–321.
6.
Bar-OzB.PellerinB.PaciorekC. (2003). Population baseline meconium fatty acid ethyl esters among infants of nondrinking women in Toronto. Drug Monitor, 25(3), 271–278.
7.
BarrH. M. & StreissguthA. P. (2001). Identifying maternal self reported alcohol use associated with foetal spectrum disorders. Alcoholism: Clinical and Experimental Research, 23(2), 2837.
8.
BergmanU.RosaF. & BaumC. (1992). Effects of exposure to benzodiazepines during fetal life. Lancet, 340, 694–696.
9.
Calvo BotellaH. (2003). Alcohol y neuro psicología. (Alcohol and neuropsychology)Trastornos adictivos, 5(3), 256–268.
10.
Canada's Drug Strategy Division. (2000). Fetal alcohol syndrome/fetal alcohol effects and the effects of other substance use during pregnancy. Available at http://www.cds-sca.com.
11.
Centers for Disease Control (1989). Urogenital anomalies in the offspring of women using cocaine during early pregnancy, Atlanta, 1968–1980: Birth defects and genetic diseases. Morbidity and Mortality Weekly Report, 38(31), 536, 541–542.
12.
ChambersC.Hernandez DiazS.Van MartinL. (2006). Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. New England Journal of Medicine, 354, 579–587.
13.
ChanD.CapraraD.BlenchetteP.KleinJ. & KorenG. (2004). Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke. Clinical Biochemistry, 37(6), 429–438.
14.
ChasnoffJ.BurnsK.SchnollS. (1985). Cocaine use in pregnancy. New England Journal of Medicine, 313, 666–669.
15.
CIOMS (1991) International Guidelines for Ethical Review of Epidemiological Studies. Geneva, Switzerland: Council for International Organizations of Medical Sciences (CIOMS). http://www.cioms.ch/frame_1991_texts_of_guidelines.htm.
16.
CnattingiusS.SignorelloL. B.AnnerénG. (2000). Caffeine intake and the risk of first-trimester spontaneous abortion. New England Journal of Medicine, 343(25), 1839–1845.
17.
DeraufC.KatzA. & EasaD. (2003). Agreement between maternal self-reported ethanol intake and tobacco use during pregnancy and meconium assays for fatty acid ethyl esters and cotinine. American Journal of Epidemiology, 158, 705–709.
18.
EspinozaR. (1999). Efectos de algunas drogas sobre el feto y el recién nacido. (Effects of some drugs on the fetos and the newborn) In Obstetricia, 3rd ed., ed. SantiagoP. A. and DonosoE., 989–1007. Santiago: Publicaciones Técnicas Mediterráneo.
19.
FuchsF.FuchsA.PobleteV. F. & RiskA. (2004). Effects of alcohol on threatened premature labor. American Journal of Obstetrics and Gynecology, 99(5), 627–637.
20.
GerberdingJ. L.CorderoJ. & FloydL. (2005). Fetal alcohol syndrome: Guidelines for referral and diagnosis. 3rd ed.Atlanta: CDC National Center on Birth Defects and Developmental Disabilities.
HuestisM. A. & ChooR. E. (2002). Drug abuse's smallest victims: In utero drug exposure. Forensic Science International128(2): 20–30.
23.
HutsonJ. R.MagriR.SuarezH.MíguezH.GareriJ. & KorenG. (2006). Alcohol Consumption During Pregnancy in Uruguay as Measured by Fatty Acid Ethyl Esters in Meconium. Presented at the annual meeting of the Research Society on Alcoholism, June 23–29, Baltimore, MD, USA. Abstract in Alcoholism: Clinical and Experimental Research30(6, Supplement 1):110A.
24.
JaakkolaJ. K. & GisslerM. (2004). Maternal smoking in pregnancy, fetal development, and childhood asthma. American Journal of Public Health, 94(1), 136–141.
25.
JonesK. L. & SmithD. W. (1973a). Recognition of the fetal alcohol syndrome in early infancy. Lancet, 2(7836), 999–1001.
26.
JonesK. L.SmithD. W.UlelandC. N. & StreissguthA. P. (1973b). Patterns of malformations in offspring of chronic alcoholic mothers. Lancet, 1(7815), 1267–1271.
Junta Nacional de Drogas. (2001). Tercera encuesta nacional en hogares sobre consumo de drogas en población general. (Third national survey on drug consumption in general population) Available at www.infodrogas.gub.uy.
29.
KullanderS. & KallenB. (1971). A prospective study of smoking and pregnancy. Acta obstetricia et gynecologica Scandinavica, 50, 83–94.
30.
LacassieH. & NúñezG. (2000). Drogas y embarazo: Revisión bibliografica. (Drugs and pregnancy: Biblyographical review)Revista Chilena de Anestesia, 29(2).
31.
LaegreidL.OlegardR.WahlstromJ. & ConradiN. (1989). Teratogenic effects of benzodiazepine use during pregnancy. Journal of Pediatrics, 114, 126–131.
32.
LarsenL. G. & GraemN. (1999). Morphological findings and value of placental examination at fetal and perinatal autopsy. Acta pathologica, microbiologica, et immunologica Scandinavica, 107(3), 337–345.
33.
LemoineP.HarouseauH.BorteryuJ. T. & MenuetJ. C. (2003). Les enfants des parents alcooliques: Anomalies observées a propos de 127 cas. (Children of alcoholic parents: Anomalies in 127 cases)Therapeutic Drug Monitoring, 25(2), 132–136.
34.
MannA. (2004). Smoking exposure in uterus increases risk of later addiction. NIDA Notes, 19(4).
35.
MayP. A.BrookeL.GossageJ. P. (2000). Epidemiology of fetal alcohol syndrome in a South African community in the Western Cape Province. American Journal of Public Health, 90, 1905–1912.
36.
MayP. A. & GossageJ. (2001). Estimating the prevalence of fetal alcohol syndrome: A summary. Alcohol Research and Health, 25, 159–167.
37.
MíguezH. (2004). La alcoholización juvenil en la Argentina (Youth alcohol use in Argentina)Acta Psiquiátrica y Psicologica de América Latina, 50(1), 43–47.
38.
MooreC.JonesJ.LewisD. & BuchiK. (2003). Prevalence of fatty acid ethyl esters in meconium specimens. Clinical Chemistry, 49, 133–136.
39.
OstreaE.HernandezJ.BielawskiD. (2006). Fatty acid ethyl esters in meconium: Are they biomarkers of fetal alcohol exposure and effect?Alcoholism: Clinical and Experimental Research, 30(7), 1152–1159.
40.
RathmellJ.ViscomiC. & AshburnM. (1997). Management of nonobstetric pain during pregnancy and lactation. Anesthesia and Analgesia, 85, 1074–1087.
41.
RosenbergL.MitchellA.ParsellsJ. (1983). Lack of relation of oral clefts to diazepam use during pregnancy. New England Journal of Medicine, 309, 1282–1285.
42.
Sistema Informatico Perinatal (SIP) en el Uruguay. (Uruguayan perinatal informatic system) (2001). Montevideo: Publicación científica del CLAP.
43.
SokolR. J. (1981). Alcohol and abnormal outcomes of pregnancy. Canadian Medical Association Journal, 125(2), 1438.
44.
TaylorB. (2007). Alcohol consumption, outcomes and burden of disease in the Americas. Toronto, Canada: Center for Addiction and Mental Health.
45.
ToddR. & TriunfoP. (2006). Bajo peso al nacer en el Uruguay: Implicaciones para las políticas de salud. (Low birth weight in Uruguay: Implications for health policies) Department of Economics working paper no. 1706, Universidad de la República. Available at http://decon.edu.uy/publica/2006/1706.pdf.
46.
Vander VeenF. & FoxH. (1982). The effect of cigarette smoking on the human placenta: A light and electron microscopic study. Placenta, 3, 243–256.
47.
World Health Organization (2004). Global status report on alcohol. Geneva, Switzerland: WHO.
48.
ZuckermanB.FrankD.HingsonR. (1989). Effects of maternal marijuana and cocaine use on fetal growth. New England Journal of Medicine, 29(2), 320, 762–768.
